Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Binlin Lin"'
Autor:
Caiqi Liu, Jiaqi Shi, Binlin Lin, Meng Zhou, Dan Shan, Jianhua Nie, Yan Wang, Yanqiao Zhang, Peng Han, Tongsen Zheng
Publikováno v:
Current gene therapy.
Background: A novel CDK4/6 inhibitor SHR6390 has shown significant anti-tumor effects. However, its role in hepatocellular carcinoma(HCC) remains unknown. Objective: To explore the inhibitory effect of combination treatment with SHR6390 and cabozanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c45db80f0041553b39d570a5389fd7
https://pubmed.ncbi.nlm.nih.gov/36017825
https://pubmed.ncbi.nlm.nih.gov/36017825
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 144:2329-2337
Purpose Hepatocellular carcinoma (HCC) is a complicated disease with low survival rate due to frequent recurrence and the lack of efficient therapies. For advanced HCC, sorafenib, as the only approved first-line drug for HCC, improves the survival to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a6f179015f8dd4278aeb4538376495
https://doi.org/10.1007/s00432-018-2740-3
https://doi.org/10.1007/s00432-018-2740-3
Autor:
Song Wang, Caiqi Liu, Meng Zhou, Tingyu Cao, Tongsen Zheng, Binlin Lin, Xiaobo Li, Jiaqi Shi, Shengnan Luo, Xiao Zhang
Publikováno v:
Cellular Immunology. 366:104384
Despite impressive clinical success, cancer immunotherapy based on immune checkpoint blockade remains ineffective in colorectal cancer (CRC). Stimulator of interferon genes (STING) is a novel potential target and STING agonists have shown potential a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba0c9acb2c0f5cc6a11e21a536945ad
https://doi.org/10.1016/j.cellimm.2021.104384
https://doi.org/10.1016/j.cellimm.2021.104384
Autor:
Ruiqi Liu, Shuangjia Wang, Yanqiao Zhang, Chunhui Zhang, Lianxin Liu, Shuli Tang, Meng Zhou, Jiguang Han, Jianhua Nie, Boshi Sun, Binlin Lin, Huawen Shi, Lantian Tian, Li Wu, Yingjian Liang, Yuejin Li, Benjie Xu, Tongsen Zheng, Jiabei Wang, Guangyu Wang, Kunmei Gong
Publikováno v:
Cancer letters. 443
Gankyrin plays important roles in tumorigenicity and metastasis of hepatocellular carcinoma (HCC). We have for the first time investigated the effects of Gankyrin on glycolysis and glutaminolysis both in vitro and in vivo, including in patient-derive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1d9e1d5fa6795299ab1e6b1bbc7794
https://pubmed.ncbi.nlm.nih.gov/30503555
https://pubmed.ncbi.nlm.nih.gov/30503555